Showing results (31-40 of 1,237) with videos related to
Sort By:
Pageof 124
Journal of Inherited Metabolic Disease|October 14, 2000
Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuriaV Leuzzi, M C Bianchi, M Tosetti, et al.Clinical Prostate Cancer|January 8, 2005
Early use of chemotherapy in conjunction with radical prostatectomyJoshi J Alumkal, Michael A CarducciExpert Opinion on Investigational Drugs|January 6, 2010
Combining low-dose cyclophosphamide with GM-CSF-secreting prostate cancer immunotherapy enhances antitumor immune effectsEmmanuel S Antonarakis, Michael A CarducciExpert Opinion on Investigational Drugs|August 18, 2018
Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directionsPedro Isaacsson Velho, Michael A CarducciExpert Review of Molecular Diagnostics|June 3, 2014
Molecular genetics and diagnosis of phenylketonuria: state of the artNenad Blau, Nan Shen, Carla CarducciMolecular Genetics and Metabolism|July 1, 2015
Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiencyClaudia Carducci, Silvia Santagata, Jennifer Friedman, et al.Clinical Genitourinary Cancer|January 7, 2011
Future directions in castrate-resistant prostate cancer therapyEmmanuel S Antonarakis, Michael A CarducciHaemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Long-term follow-up of liver function in Italian haemophilic patientsN Cecconi, A Carducci, F PanicucciClinical Advances in Hematology & Oncology : H&O|September 17, 2005
Novel therapeutic approaches to advanced prostate cancerAndrew J Armstrong, Michael A CarducciHematology/Oncology Clinics of North America|July 25, 2006
New targets in the management of prostate cancerElisabeth I Heath, Michael A CarducciPageof 124